Palbociclib and Letrozole in Advanced Breast CancerRichard S. Finn, Dennis J. Slamon, Janice M. Walshe et al.|New England Journal of Medicine|2016Cited by 2.9k
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trialMassimo Cristofanilli, Dennis J. Slamon, Nicholas C. Turner et al.|The Lancet Oncology|2016Cited by 1.8k
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast CancerNicholas C. Turner, Massimo Cristofanilli, Dennis J. Slamon et al.|New England Journal of Medicine|2018Cited by 1.3k
Frequent Mutations of Chromatin Remodeling Gene <i>ARID1A</i> in Ovarian Clear Cell CarcinomaSiân Jones, Nickolas Papadopoulos, Tian‐Li Wang et al.|Science|2010Cited by 1.2k
Cycling cancer persister cells arise from lineages with distinct programsYaara Oren, Aviv Regev, Katerina Politi et al.|Nature|2021Cited by 514